BioNano Genomics
OverviewSuggest Edit
BioNanomatrix develops nanoscale imaging and analytic platforms that are designed to analyze DNA and other genome-related peptides and proteins. The Company's technology provides analysis of genomic, epigenomic, and proteomic information with sensitivity at the single molecule level. Its products are used in genetic diagnostics, personalized medicine, and biomedical research applications.
| Type | Public | |
| Founded | 2002 | |
| HQ | San Diego, CA, US | Map |
| Website | bionanogenomics.com | |
| Employee Ratings | More | |
| Overall Culture | A+ | More |
Recent NewsAll News
- Bionano Genomics Announces Peer-Reviewed Publication from Johns Hopkins University Outlining a Stepwise Approach to the Adoption of Optical Genome Mapping for Cancer Analysis
- Bionano Genomics Announces the Appointment of Stephanie Hoyle as VP Corporate Marketing and Alex Helm as VP Strategic Product Marketing
- Bionano Genomics Announces Major Updates to Its Solve™ and Access™ Data Solutions Adding Significant New Variant Detection, Analysis and Reporting Capabilities for Optical Genome Mapping on the Saphyr® System
- Bionano Genomics to Report Third Quarter 2021 Financial Results and Host a Conference Call and Webcast on November 4, 2021
Key People/Management at BioNano Genomics
Erik Holmlin
President, Chief Executive Officer & Director
David L. Barker
Chairman
Mark Oldakowski
Chief Operating Officer
Christopher J. Twomey
Director
Christopher Stewart
Chief Financial Officer
Albert Luderer
Director
BioNano Genomics Office Locations
BioNano Genomics has offices in San Diego and London
San Diego, CA, US (HQ)
9640 Towne Centre Dr #100
London, GB
90 Fetter Ln, Holborn
BioNano Genomics Financials and Metrics
BioNano Genomics Revenue
BioNano Genomics's revenue was reported to be $8.5 m in FY, 2020
| USD | |
|---|---|
Revenue (Q1, 2021) | 3.2m |
Gross profit (Q1, 2021) | 1.0m |
Gross profit margin (Q1, 2021), % | 32.9% |
Net income (Q1, 2021) | (9.9m) |
EBIT (Q1, 2021) | (11.2m) |
Market capitalization (12-Nov-2021) | 1.5b |
Closing stock price (12-Nov-2021) | 5.1 |
Cash (31-Mar-2021) | 362.1m |
EV | 1.1b |
BioNano Genomics's current market capitalization is $1.5 b.
Annual
Annual
Annual
Quarterly
| USD | FY, 2016 |
|---|---|
Debt/Equity | -3.6 x |
Debt/Assets | 0.4 x |
Financial Leverage | -8 x |
BioNano Genomics Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| Lineagen | August 24, 2020 | |
| BioNano Genomics (Shanghai) Trading Co. | ||
| BioNano Genomics UK |
BioNano Genomics Revenue Breakdown
BioNano Genomics revenue breakdown by geographic segment: 46.5% from Asia Pacific, 13.5% from EMEIA and 40.0% from North America
BioNano Genomics Cybersecurity Score
BioNano Genomics Online and Social Media Presence
32.13k Twitter followers
BioNano Genomics has 32.13k Twitter Followers. The number of followers has increased 0.7% month over month and increased 1.2% quarter over quarter
BioNano Genomics's Trends
Twitter Engagement Stats for @bionanogenomics
2.6k
Tweets
1.4k
Following
32.1k
Followers
27
Tweets last 30 days
115.6
Avg. likes per Tweet
100%
Tweets with engagement
BioNano Genomics Company Culture
Overall Culture
A+
95/100
CEO Rating
A+
90/100
Compensation
A+
100/100
BioNano Genomics News and Updates
November 22, 2021
Bionano Genomics Announces Peer-Reviewed Publication from Johns Hopkins University Outlining a Stepwise Approach to the Adoption of Optical Genome Mapping for Cancer Analysis
SAN DIEGO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), provider of optical genome mapping (OGM) solutions on the Saphyr® system and the leading software for genomic data visualization, interpretation and reporting, today announced the publication of a study by Johns Hopkins Un…
November 04, 2021
Bionano Genomics Announces the Appointment of Stephanie Hoyle as VP Corporate Marketing and Alex Helm as VP Strategic Product Marketing
SAN DIEGO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced that two former Illumina executives, Stephanie Hoyle and Alex Helm, have j…
November 03, 2021
Bionano Genomics Announces Major Updates to Its Solve™ and Access™ Data Solutions Adding Significant New Variant Detection, Analysis and Reporting Capabilities for Optical Genome Mapping on the Saphyr® System
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced the release of Bionano Solve™ version 3.7 and Bionano Access™ version 1.7 …
October 28, 2021
Bionano Genomics to Report Third Quarter 2021 Financial Results and Host a Conference Call and Webcast on November 4, 2021
SAN DIEGO, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Thursday, November 4, 2021 at 4:30 p.m. Eastern Time to report financial results for the third quarter ended September 30, 2021 and to highligh…
October 15, 2021
Bionano Genomics Announces American Society of Human Genetics Presentations Featuring Optical Genome Mapping for Genetic Disease and Cancer Research Applications
SAN DIEGO, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced the American Society of Human Genetics (ASHG) conference lineup of custome…
October 12, 2021
Thinking about buying stock in Gaotu Techedu, Camber Energy, Sphere 3D, BioNano Genomics, or Southwest Airlines?
NEW YORK, Oct. 12, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GOTU, CEI, ANY, BNGO, and LUV. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....
BioNano Genomics Blogs
October 12, 2021
Bionano Genomics Conference Call
The post Bionano Genomics Conference Call appeared first on Bionano Genomics.
July 28, 2021
2021 Bionano Second Quarter Financial Results Call
The post 2021 Bionano Second Quarter Financial Results Call appeared first on Bionano Genomics.
July 28, 2021
Annual Cancer Genomics Consortium (CGC) Meeting, August 1 – 4, 2021
The post Annual Cancer Genomics Consortium (CGC) Meeting, August 1 – 4, 2021 appeared first on Bionano Genomics.
July 02, 2021
2021 Ladenburg Thalmann Healthcare Conference
The post 2021 Ladenburg Thalmann Healthcare Conference appeared first on Bionano Genomics.
June 10, 2021
2021 Bionano Annual Shareholders Meeting
The post 2021 Bionano Annual Shareholders Meeting appeared first on Bionano Genomics.
May 25, 2021
Bionano Genomics to Present at the 2021 Oppenheimer MedTech, Tools & Diagnostic Summit
The post Bionano Genomics to Present at the 2021 Oppenheimer MedTech, Tools & Diagnostic Summit appeared first on Bionano Genomics.
BioNano Genomics Frequently Asked Questions
When was BioNano Genomics founded?
BioNano Genomics was founded in 2002.
Who are BioNano Genomics key executives?
BioNano Genomics's key executives are Erik Holmlin, David L. Barker and Mark Oldakowski.
How many employees does BioNano Genomics have?
BioNano Genomics has 77 employees.
What is BioNano Genomics revenue?
Latest BioNano Genomics annual revenue is $8.5 m.
What is BioNano Genomics revenue per employee?
Latest BioNano Genomics revenue per employee is $110.4 k.
Who are BioNano Genomics competitors?
Competitors of BioNano Genomics include BaseHealth, Predicine and Mammoth Biosciences.
Where is BioNano Genomics headquarters?
BioNano Genomics headquarters is located at 9640 Towne Centre Dr #100, San Diego.
Where are BioNano Genomics offices?
BioNano Genomics has offices in San Diego and London.
How many offices does BioNano Genomics have?
BioNano Genomics has 3 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies